Penumbra ROA 2014-2022 | PEN
Current and historical return on assets (ROA) values for Penumbra (PEN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Penumbra ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2022-09-30 |
$-0.03B |
$1.32B |
-2.39% |
| 2022-06-30 |
$-0.02B |
$1.33B |
-1.65% |
| 2022-03-31 |
$-0.01B |
$1.30B |
-0.63% |
| 2021-12-31 |
$0.00B |
$1.24B |
0.50% |
| 2021-09-30 |
$0.03B |
$0.97B |
3.83% |
| 2021-06-30 |
$0.02B |
$0.91B |
1.89% |
| 2021-03-31 |
$-0.00B |
$0.84B |
-0.61% |
| 2020-12-31 |
$-0.02B |
$0.82B |
-2.08% |
| 2020-09-30 |
$-0.01B |
$0.81B |
-1.37% |
| 2020-06-30 |
$0.01B |
$0.78B |
1.47% |
| 2020-03-31 |
$0.04B |
$0.66B |
6.17% |
| 2019-12-31 |
$0.05B |
$0.67B |
8.05% |
| 2019-09-30 |
$0.05B |
$0.61B |
8.06% |
| 2019-06-30 |
$0.02B |
$0.59B |
2.95% |
| 2019-03-31 |
$0.01B |
$0.57B |
2.30% |
| 2018-12-31 |
$0.01B |
$0.52B |
1.20% |
| 2018-09-30 |
$0.01B |
$0.50B |
1.63% |
| 2018-06-30 |
$0.03B |
$0.50B |
5.61% |
| 2018-03-31 |
$0.01B |
$0.49B |
2.60% |
| 2017-12-31 |
$0.00B |
$0.48B |
0.90% |
| 2017-09-30 |
$-0.01B |
$0.46B |
-1.75% |
| 2017-06-30 |
$0.01B |
$0.42B |
1.39% |
| 2017-03-31 |
$0.01B |
$0.42B |
3.06% |
| 2016-12-31 |
$0.02B |
$0.31B |
5.15% |
| 2016-09-30 |
$0.02B |
$0.30B |
6.43% |
| 2016-06-30 |
$0.01B |
$0.28B |
2.22% |
| 2016-03-31 |
$0.00B |
$0.28B |
1.00% |
| 2015-12-31 |
$0.00B |
$0.26B |
0.76% |
| 2015-06-30 |
$-0.00B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$9.289B |
$0.748B |
|
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.
|
